Recruiting first, then most recently updated. Showing 36 of 36.
- Phase 1 Clinical Study of MWN117 Injection in Healthy Participants and Participants With ObesityNot yet recruitingNCT07824804Phase 1
Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical
- Phase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes MellitusRecruitingNCT07801820Phase 2
Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical
- Phase 2 Clinical Study of MWX203 Injection Alone or in Combination With Inclisiran Sodium Injection in Patients With Mixed DyslipidemiaRecruitingNCT07803822Phase 2
Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical
- Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or ObesityRecruitingNCT07803809Phase 1
Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical
- Phase 1 Clinical Study of MWX401 Injection in Chinese Healthy Participants and Participants With Mild HypertensionRecruitingNCT07803835Phase 1
Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical
- Phase 1 Clinical Study of MWN110 Injection in Healthy Participants and Overweight or Obese ParticipantsNot yet recruitingNCT07779980Phase 1
Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical
- Phase 3 Study of MWN109 Injection in Participants With Overweight or ObesityNot yet recruitingNCT07778693Phase 3
Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical
- Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MWX205Not yet recruitingNCT07634510Phase 1
Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical
- A Study to Evaluate MWN109 Tablets in Healthy Adult ParticipantsRecruitingNCT06938269Phase 1
Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical
- To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary HypertensionRecruitingNCT07051811Not applicable
Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.
- A Study to Evaluate MWN109 Injection in Healthy SubjectsRecruitingNCT06859853Phase 1
Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical
- Study on the Efficacy and Safety of Rechargeable Implantable DBS System in the Treatment of Parkinson's DiseaseRecruitingNCT05997667Not applicable
Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.
- Safety and Efficacy of SinocrownTM Transcatheter Aortic Valve Replacement SystemEnrolling by invitationNCT05202977Not applicable
Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.
- Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS SystemNot yet recruitingNCT04995159Not applicable
Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.
- Phase Ib Clinical Study of MWN109 Injection in Participants With Overweight or ObesityCompletedNCT07787728Phase 1
Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical
- Phase 1 Clinical Study of MWN109 Injection in Healthy Chinese VolunteersCompletedNCT07787624Phase 1
Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical
- Phase 2 Clinical Study of MWN105 Injection in Participants With Overweight or ObesityCompletedNCT07804810Phase 2
Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical
- Phase 2 Study of MWN109 Tablet for Weight-Loss Maintenance in Participants With Overweight or ObesityActive, not recruitingNCT07804797Phase 2
Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical
- Phase 1 Clinical Study of MWN105 Injection in Healthy Chinese VolunteersCompletedNCT07801313Phase 1
Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical
- A Study to Evaluate Different Administration Conditions and the Food Effect of MWN109 Tablets in Chinese ParticipantsCompletedNCT07801326Phase 1
Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical
- Phase 1 Clinical Study of MWX203 Injection in Healthy SubjectsActive, not recruitingNCT07799025Phase 1
Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical
- Phase 2 Study of MWN109 Tablet in Participants With Overweight or ObesityCompletedNCT07791524Phase 2
Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight or ObesityCompletedNCT07791654Phase 2
Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical
- Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With OverweightActive, not recruitingNCT07791537Phase 2
Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical
- Phase I Clinical Study of MWN109 Tablets in Healthy Chinese ParticipantsCompletedNCT07787611Phase 1
Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical
- To Evaluate the Efficacy and Safety of Multi-parameter Non-Invasive Glucose Sensors for for Blood Glucose MeasurementCompletedNCT06017349Not applicable
Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.
- Treatment of Urethral Stricture With Urethral Drug BallStatus unknownNCT05812482Not applicable
Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.
- Ultrasound Ablation for Essential Hypertension(FIM)Status unknownNCT05795829Not applicable
Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.
- Clinical Trials of Pulsed Sonic Balloon Dilatation Catheter and Pulsed Sonic GeneraterStatus unknownNCT05406869Not applicable
Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.
- Long-term Efficacy of Drug-coated Balloon Versus Drug-eluting Stent in Large de Novo Coronary LesionsStatus unknownNCT05101005Not applicable
Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.
- A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel DiseaseStatus unknownNCT04953117Not applicable
Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.
- NeoVas Bioresorbable Coronary Scaffold Registry StudyStatus unknownNCT02305472Not applicable
Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.
- NeoVas Bioresorbable Coronary Scaffold Randomized Controlled TrialStatus unknownNCT02305485Not applicable
Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.
- NeoVas Bioresorbable Coronary Scaffold First-in-Man StudyStatus unknownNCT02195414Phase 1
Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.
- Efficacy and Safety of Nano+ Polymer-free Sirolimus-Eluting Stent: A Optical Coherent Tomography StudyStatus unknownNCT01925027Phase 4
Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.
- LEPU Renal Denervation System for Resistant HypertensionCompletedNCT02536326Phase 3
Sponsor listed in the registry: Lepu Medical Technology (Beijing) Co., Ltd.